Table of contents
Pharmaceutical manufacturers have until November 27, 2023 to implement capabilities for 100% electronic, interoperable exchange of compliance data in the GS1 Electronic Product Code Information Services (EPCIS) format. Cardinal Health—one of the Big 3 wholesalers—expects their suppliers to be onboarded for EPCIS several months before the November deadline. The company even made reference to potential fines or “discretionary fees” that could be levied for latecomers to the onboarding process.
The good news is that as an existing TraceLink Product Track customer, your company has already licensed the required EPCIS capability! But there are some simple but critical steps you need to take to ensure that the capability is activated properly.
Watch this on-demand webinar for TraceLink customers to get a five-step guide on how to activate your pre-licensed EPCIS capability for DSCSA 2023 compliance. Register to attend this live webinar now and you will learn:
- How to transition to the EPCIS file exchange format from the current ASNs you’re now sending.
- How to quickly and easily work with the TraceLink Services and Network Success Team to execute an optimized and battle-tested activation process that minimizes disruptions and ensures a smooth go-live.
- How the TraceLink Product Track Solution reduces the time, cost, and risk associated with DSCSA 2023 compliance.
TraceLink Product Track is the fastest, lowest risk, and most economical path to compliance with the final phase of DSCSA. Fill out the form to register for this important customer on-demand webinar now!
Featured Speakers:
Dan Walles,
General Manager,
Track & Trace/Compliance
Caitlin Czulada,
Director,
Center of Excellence
